GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Astellas Pharma Inc (STU:YPH) » Definitions » 5-Year Yield-on-Cost %

Astellas Pharma (STU:YPH) 5-Year Yield-on-Cost % : 10.42 (As of Apr. 27, 2025)


View and export this data going back to . Start your Free Trial

What is Astellas Pharma 5-Year Yield-on-Cost %?

Astellas Pharma's yield on cost for the quarter that ended in Dec. 2024 was 10.42.


The historical rank and industry rank for Astellas Pharma's 5-Year Yield-on-Cost % or its related term are showing as below:

STU:YPH' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 2.86   Med: 4.54   Max: 10.68
Current: 10.42


During the past 13 years, Astellas Pharma's highest Yield on Cost was 10.68. The lowest was 2.86. And the median was 4.54.


STU:YPH's 5-Year Yield-on-Cost % is ranked better than
88.3% of 513 companies
in the Drug Manufacturers industry
Industry Median: 2.3 vs STU:YPH: 10.42

Competitive Comparison of Astellas Pharma's 5-Year Yield-on-Cost %

For the Drug Manufacturers - General subindustry, Astellas Pharma's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Astellas Pharma's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Astellas Pharma's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Astellas Pharma's 5-Year Yield-on-Cost % falls into.


;
;

Astellas Pharma 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Astellas Pharma is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Astellas Pharma  (STU:YPH) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Astellas Pharma 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Astellas Pharma's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Astellas Pharma Business Description

Traded in Other Exchanges
Address
2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, JPN, 103-8411
Astellas Pharma Inc is a specialty global pharmaceutical company. The company focuses on accelerating the discovery, development and commercialization of ground-breaking innovations that could redefine expectations of care for difficult-to-treat diseases. The group is committed to driving innovation in immuno-oncology, gene therapy, mitochondria, blindness and regeneration, and targeted protein degradation. The company operates its business in approximately 70 countries around the world. Its core products include anticancer agents like XTANDI, XOSPATA, and PADCEV; VEOZAH for the treatment of vasomotor symptoms due to menopause; Betanis / Myrbetriq / BETMIGA for the treatment of overactive bladder (OAB); and Prograf, an immunosuppressant for organ transplantation.

Astellas Pharma Headlines

No Headlines